X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Wall Street Cautiously Optimistic After Gene Therapy Deals

    RoboCap: A Robotic Capsule to Improve Gut Drug Delivery

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Wall Street Cautiously Optimistic After Gene Therapy Deals

    RoboCap: A Robotic Capsule to Improve Gut Drug Delivery

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

Blockchain & supply chain resilience in the wake of Covid-19

Content Team by Content Team
27th April 2020
in News
Blockchain & supply chain resilience in the wake of Covid-19

The world is in the midst of the largest remote working experiment it has ever seen, reinforcing the value of reliable data. More than ever before, we need to know where our data comes from and whether or not it can be trusted. We are bombarded with information on a daily basis across the various different communication mediums we use in our professional and personal lives. This news is then passed onto each other sequentially, through emails, WhatsApp messages and other apps and social media platforms, and the velocity is only increasing, particularly in isolation.

Supply chains operate in the same way, linked sequentially in a chain that passes information from one user to the next. We rely on each constituent to do their part and pass on information quickly and accurately, but, like a Chinese whisper, the data is never the same at the end as it is at the beginning. However, what if we could guarantee that this information is accurate, immutable and derived from one of the most trusted sources of data capture? How could supply chains be transformed through the adoption of blockchain technology in times of crisis and in times of normality?

Most organisations are active in two supply chains, one physical and one financial. The financial one has the distinct advantage of being born digital while the physical one remains analogue and therefore significantly slower. Both need to be measured, monitored and tracked, so that the data extracted can be analysed and used to drive the next level of industrial automation, Industry 4.0.

However, what if one link is out of action being furloughed or unwell? How can the adjacent links maintain the bridge and keep the information and the supply chain moving?

COVID-19 risks to each link/person in the supply chain, much like a row of dominoes toppling until one link is missing. According to McKinsey, some 38% of supply chains are digitised and very few are using blockchain technology – the key to unlocking the connectivity.

Today’s supply chains are global, connected and generally efficient. Still, Covid-19 has placed a spotlight on our weaknesses. The focus on cost efficiency throughout supply chains demands evidence-based delivery: every component and process needs to be tracked to ensure that the final product can be verified and tracked back to its component parts, identifying where cost savings can be made and whether organisations are operating in the most efficient way possible.

Blockchain is the technology behind a distributed network of computers that can be used to store data securely but which, uniquely, has a single memory. That means data cannot be freely copied and edited to create an alternative version of the truth, which is why blockchain technologists refer to it as the “trust platform”. In the enterprise context, the blockchain would be used as a private permissioned framework for a group of stakeholders, such as suppliers, customers and regulators.

A recent survey by HFS Research and Wipro found that of 318 senior executives polled, 75 percent consider blockchain to be a strategic priority. This will only continue to grow as accountability, auditability and cost efficiencies within supply chains are increasingly prioritised. After all, duplication, checking and re-checking data and its sources costs time and money, slowing down supply chain processes. Furthermore, nearly 60% of these C-level executives anticipate that consensus-driven trust allows them to plan entirely new business models that were not possible before blockchain.

The global impact of COVID-19 will force us to reconsider what we want from our supply chains, whether this be costs efficiencies, or increased speed and agility. Unlike a row of dominoes, we also need supply chains that can withstand the next pandemic by creating a circle of trust, and not a sequential line with points that can fail.

Previous Post

Cytovance and Akshaya Bio Announce Collaboration Agreement of Therapeutics for Treatment of Coronavirus and Hepatitis B Virus Infections

Next Post

CENTOGENE Releases a New Swab Product to Facilitate the Simple Diagnosis of COVID-19

Related Posts

Clinical Trials

Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

8th November 2022
Facilities & Operation

India Seeks Better Pharma Market Access In The UK: Official

8th November 2022
First Virtual Drug Study Tests 2 Likely Alzheimer Therapies
Clinical Trials

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

7th November 2022
Facilities & Operation

CPhI Pharma Index Shows Unprecedented Global Pharma Optimism

5th November 2022
$2 Million Gene Therapy Might Become The Standard In The US
Drug Development

$2 Million Gene Therapy Might Become The Standard In The US

5th November 2022
News

Cancer Medicine Prices Jump 53% In Five Years In The U.S

3rd November 2022
Next Post
CENTOGENE Releases a New Swab Product to Facilitate the Simple Diagnosis of COVID-19

CENTOGENE Releases a New Swab Product to Facilitate the Simple Diagnosis of COVID-19

Latest News

Clinical Trials

Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

8th November 2022
Facilities & Operation

India Seeks Better Pharma Market Access In The UK: Official

8th November 2022
First Virtual Drug Study Tests 2 Likely Alzheimer Therapies
Clinical Trials

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

7th November 2022
Facilities & Operation

CPhI Pharma Index Shows Unprecedented Global Pharma Optimism

5th November 2022
$2 Million Gene Therapy Might Become The Standard In The US
Drug Development

$2 Million Gene Therapy Might Become The Standard In The US

5th November 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In